Posts made in September, 2012

BioSavita Appoints James Kuo, M.D., M.B.A., Chairman and Chief Executive Officer

Sep 27, 2012 in Press Releases

September 27, 2012 BioSavita, Inc. announced today that its board has appointed James Kuo, M.D., M.B.A., Chairman and Chief Executive Officer. He plans to lead the company’s growth through development of its portfolio of biosimilar products and additional corporate partners for its Twin Cassette® yeast expression technology, which allows rapid production of fully functional antibodies in secreted form. Dr. Kuo has over 20 years of life science industry experience as a venture capitalist, pharmaceutical business development executive and...

BioSavita Named Semifinalist in Accelerate Michigan Innovation Competition

Sep 22, 2012 in Press Releases

September 2012 BioSavita is a biotechnology company focused on accelerating therapeutic antibody development for our Antibodies are the newest pharmaceutical blockbusters with $56 billion in aggregate sales in 2011 growing at 13–15% CAGR to over $70B by 2015. BioSavita’s CEO has successfully led venture-backed as well as publicly traded biotech team includes two of the top-licensing professionals for antibody expression platforms. The company has developed and validated its Twin Cassette™ yeast expression platform technology....